Fluarix Approval History

• FDA approved: Yes (First approved August 31st, 2005)
• Brand name: Fluarix
• Generic name: influenza virus vaccine, inactivated
• Company: GlaxoSmithKline
• Treatment for: Influenza Prophylaxis

Fluarix (influenza virus vaccine, inactivated) is an influenza virus vaccine indicated for adults and children (3 years and older) for the prevention of influenza disease.

FDA Approval History for Fluarix

Date	Article
Dec 17, 2012	FDA Approves GlaxoSmithKline's Fluarix Quadrivalent - Four-strain Seasonal Influenza Vaccine for Use in the U.S.
Oct 19, 2009	FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use
Aug 31, 2005	Fluarix GlaxoSmithKline - Treatment for Influenza Vaccination
May 25, 2005	GlaxoSmithKline Submits Biologics License Application for FDA Approval of Fluarix

See also...

Fluarix (influenza virus vaccine, inactivated) Consumer Information

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.